News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Boehringer Ingelheim Corporation Building $69 Million Plant in China Medical City


6/1/2012 2:10:25 PM

by Richard Daverman, PhD

June 1, 2012 -- Boehringer Ingelheim will invest $69 million into a veterinary vaccine medicine production facility, which will be built in Taizhou China Medical City. The new manufacturing plant follows closely on BI’s $15 million investment into an animal health R&D lab in Shanghai’s Zhangjiang Hi-Tech park, which opened in March of this year. The company wants to increase its market share in the Asia-specific animal vaccine sector. More details....


Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES